SCHEMBL30007668

SCHEMBL30007668

CCN(CC)c1ccc(Cn2ccc3cc(-c4ccc(S(=O)(=O)C(C)C)cc4)cnc32)cc1

nearest known ligand 0.38

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
CNR2 P34972 9/20 0.37
GABRA2 P47869 2/20 0.37
PTGS2 P35354 1/20 0.36
CNR1 P21554 5/20 0.34
ATR Q13535 3/20 0.34
ATM Q13315 2/20 0.34
GLO1 Q04760 2/20 0.33
PRKDC P78527 1/20 0.33
PTGDR2 Q9Y5Y4 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30007739 0.71 NAMPT (0.43) CNR1ATR
SCHEMBL30008206 0.67 CLK1 (0.43) ATR
SCHEMBL30007248 0.67 ATR (0.40) CNR2ATR
SCHEMBL16804367 0.63 HDAC6 (0.53) GLO1
SCHEMBL18852659 0.63 HDAC8 (0.42) CNR2CNR1GLO1
SCHEMBL18108895 0.63 HDAC6 (0.58)
SCHEMBL18108862 0.62 HDAC6 (0.57) GLO1
SCHEMBL16804239 0.61 CYP11B2 (0.44) GLO1
SCHEMBL10060466 0.60 CA12 (0.46)
SCHEMBL18125645 0.60 HDAC6 (0.49)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022237922-A1 ANTITUMOR COMPOUNDS BASED ON NITROGEN HETEROCYCLES AND USE THEREOF AS MEDICAMENTS FAKULTNI NEMOCNICE HRADEC KRALOVE (CZ) 2022-11-17 WO claimed